Dachaigh › Liomfoma Neo-Hodgkin › Oregon › Portland
Sgrùdaidhean clionaigeach Liomfoma Neo-Hodgkin ann an Portland, OR
Tha 15 sgrùdaidhean airson Liomfoma Neo-Hodgkin a’ lorg phàirtichean aig làraichean ann agus timcheall air Portland (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
A’ fastadhÌre 1/2
- Oregon Health and Sciences University, Portland
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
A’ fastadhÌre 2
- Providence Health & Services, Portland
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
A’ fastadhÌre 1
- Oregon Health & Science University (OHSU), Portland
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
A’ fastadhÌre 2
- Research Site, Portland
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
A’ fastadhÌre 2
- Providence Portland Medical Center, Portland
- Providence St. Vincent Medical Center, Portland
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
A’ fastadhÌre 1/2
- Oregon Health & Science University, Portland
Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU
A’ fastadhSgrùdadh amharc
- Oregon Health and Science University Knight Cancer Institute, Portland
DALY II USA/ MB-CART2019.1 for DLBCL
A’ fastadhÌre 2
- Oregon Health and Science University Knight Cancer Institute, Portland
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
A’ fastadhSgrùdadh amharc
- Oregon Health & Science University/Doernbecher Children's Hospital, Portland
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
A’ fastadhÌre 1/2
- Providence Neurological Specialties West, Portland
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
A’ fastadhSgrùdadh amharc
- Kaiser Permanente Northwest, Portland
Study of SGR-1505 in Mature B-Cell Neoplasms
A’ fastadhÌre 1
- Oregon Health and Science University - Knight Cancer Institute, Portland
Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy
A’ fastadhSgrùdadh amharc
- Local Institution - 0016, Portland
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
A’ fastadhSgrùdadh amharc
- Massive Bio SYNERGY-AI site, Portland
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
A’ fastadhÌre 1
- Oregon Health & Science University, Portland
Sgrùdaidhean Liomfoma Neo-Hodgkin ann am bailtean eile
- New York City, NY31 sgrùdaidhean
- Houston, TX31 sgrùdaidhean
- Boston, MA26 sgrùdaidhean
- Nashville, TN21 sgrùdaidhean
- Philadelphia, PA20 sgrùdaidhean
- Baldwin Park, CA19 sgrùdaidhean
- Washington, DC18 sgrùdaidhean
- Chicago, IL18 sgrùdaidhean
- Atlanta, GA18 sgrùdaidhean
- Milwaukee, WI18 sgrùdaidhean
- Columbus, OH18 sgrùdaidhean
- Dallas, TX17 sgrùdaidhean
Sgrùdaidhean eile ann an Portland
- Aillse Sgamhain Neo-chealla-beag46 sgrùdaidhean
- Aillse (gach seòrsa)34 sgrùdaidhean
- Aillse a' bhroilleach33 sgrùdaidhean
- Aillse Prostata33 sgrùdaidhean
- Ailse metastatach29 sgrùdaidhean
- Aillse colorectal28 sgrùdaidhean
- Cancer Ovarian27 sgrùdaidhean
- Ailseachadh nan Sgamhan26 sgrùdaidhean
- Leukemia myeloid geur25 sgrùdaidhean
- Ailse Endometrial24 sgrùdaidhean
- Carcinoma Cealla Sgamach a' Chinn agus a' Mhuineil19 sgrùdaidhean
- Cancer Pancreatic19 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.